Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial. Rossano J, Canter C, Wolf C, Favatella N, et al. Am Heart J 2026;292:107283.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rossano J, Canter C, Wolf C, Favatella N, et al. Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial. Am Heart J 2026;292:107283.
PMID: 41038603